Saxagliptin

  • 1 lab
  • Human trial2

Outcomes

1

First-phase insulin secretion

upin humans1

1 study
  1. Saxagliptin increases first-phase insulin secretion in humans (p < 0.05).

    “In treatment-specific analyses, MET, SAXA and PIO increased first-phase ISecr at 2 years (p < 0.05).”

    Human trialprediabetes2 yearsn = 15

    Long-Term Impact of Early Oral Antidiabetic Therapy on Insulin Secretion Phases in Individuals with Prediabetes (PreDM): Insights from Hyperglycemic Clamp Studies

    ADA Scientific Sessions 2026 abstract5 Jun 2026

More on First-phase insulin secretion

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months